Publications
Primary tabs
, “Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial.”, PLoS ONE, vol. 8, 2013.
, “Intensive glucose control improves kidney outcomes in patients with type 2 diabetes”, Kidney International, 2013.
, “Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials”, European Heart Journal, vol. 33, pp. 505-14, 2012.
, “Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds”, Diabetologia, vol. 55, pp. 636-643, 2012.
, “Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial”, Stroke, vol. 43, pp. 1675-7, 2012.
, “Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis”, PLoS Medicine, vol. 9, p. e1001293, 2012.
, “Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial”, in 21st European Stroke Conference, Lisbon, Portugal, May, 2012.
, ““Frugal” healthcare innovation – a global research priority”, in The Academy of Medical Sciences. New Fellows admission day 2012. , London, United Kingdom, June, 2012.
, “Study protocol: systematic review of the burden of heart failure in low- and middle-income countries”, Syst Rev, vol. 1, p. 59, 2012.
, “The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial”, Journal of the American College of Cardiology, vol. 59, pp. 1188-96, 2012.
, “Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning?”, Arch Iran Med, vol. 15, pp. 439-45, 2012.
, “A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals”, Journal of HypertensionJournal of Hypertension, vol. 29, pp. 509-19, 2011.
, “Cuts to the NHMRC budget will undermine the health of all Australians - today and in the future”, Medical Journal of AustraliaMedical Journal of Australia, vol. 194, pp. 436-7, 2011.
, “Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial”, Stroke, vol. 42, pp. 2339-2341, 2011.
, “Experiences of Chronic Disease Prevention and Control during Social Transition. ”, in China International Center for Chronic Disease Prevention, Heping Hospital of Changzhi Medical College Health Policy Roundtable 2011 - Theme: Challenges and Strategies for Chronic Disease Prevention and Control in Transitional Society, Shanxi, China, 2011.
, “Global Healthcare: Innovative Affordable Strategies for Health”, in Virgin Unite – Necker Meets Oxford. , Necker Island, British Virgin Islands, April, 2011.
, “Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts”, Kidney International, vol. 80, pp. 93-104, 2011.
, “Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts”, Kidney InternationalKidney International, vol. 79, pp. 1341-1352, 2011.
, “National Heart Foundation Visiting Lecturer: The prevention of heart disease – So much achieved for so few. ”, in Cardiac Society of Australia and New Zealand NZ Annual Scientific Meeting, Hastings, New Zealand, 2011.
, “Perindopril-based blood pressure lowering reduces major vascular and bleeding events in patients with cerebrovascular disease who use antithrombotic therapy: the PROGRESS trial.”, Stroke Society of Australasia Annual Scientific Meeting . International Journal of Stroke. 6(Suppl 1): 20, Adelaide, Australia, p. 20, 2011.
, “Practical lessons from hypertension programmes on the Indian Sub Continent and China. ”, in Medical Research Council-British Hypertension Society Workshop - Global Alliance for Chronic Disease Call for Implementation Research in Hypertension in Low and Middle Income Countries, London, United Kingdom, April, 2011.
, “Reviewing the Evidence for Thresholds & Targets – Can we do without targets? ”, in Blood Pressure Lowering Treatment Workshop -What pressures to measure and what targets to aim at?, Sarzana, Italy, 2011.
, “Risk-based prevention programmes for primary care: what evidence do we need? ”, in Cardiac Society of Australia and New Zealand NZ Annual Scientific Meeting, Hastings, New Zealand, 2011.
, “Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis”, CirculationCirculationCirculation, vol. 124, pp. 2233-42, 2011.